chevron_leftBack
As of 24 April 2025, RaySearch Laboratories AB (publ) has a market cap of $886.41M USD, ranking #8900 globally and #141 in Sweden. It ranks #867 in the Healthcare sector, and #35 in the Health Information Services industry.
Key Stats
Market Cap
$886.41MUSD
8.51B SEK
Enterprise Value
$879.53MUSD
8.52B SEK
Revenue (TTM)
$124.19MUSD
1.19B SEK
EBITDA (TTM)
$38.29MUSD
370.79M SEK
Net Income (TTM)
$21.2MUSD
203.51M SEK
EBITDA Margin
31%
Profit Margin
17%
PE Ratio
39.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Health Information Services
CEO
Johan Lof
open_in_new
Employees
416
Founded
1988
Website
raysearchlabs.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.1% | 1.9% | 2.2% | 4.4% | 51% | 100% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RAY-B
RaySearch Laboratories AB Class B
ISIN: SE0000135485
Shares Out.:
Shares Outstanding:
28.628M1
Shares Float:
25.04M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
237.00 SEK | |
|
0GRZ
RaySearch Laboratories AB Class B
ISIN: SE0000135485
|
232.79 SEK | |
|
27R
RaySearch Laboratories AB Class B
ISIN: SE0000135485
|
21.10 EUR | |
|
RSLBF
RaySearch Laboratories AB Class B
ISIN: SE0000135485
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
22.50 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) was incorporated in 1988 and is headquartered in Stockholm, Sweden.
